What is Basophils?
Basophils are the rarest white blood cells in circulation: they normally make up less than 1% of the total leukocyte count, with an absolute count of 0.02–0.10 ×10⁹/L. Like eosinophils, they are granulocytes: their cytoplasm contains granules filled with inflammatory mediators — primarily histamine, heparin, leukotriene C4, and prostaglandins. Their cell surface carries IgE receptors (FcεRI), allowing them to respond directly to allergic triggers: on contact with an allergen to which IgE is bound, they degranulate and release large amounts of histamine and other mediators. The tissue counterpart of the basophil is the mast cell, which carries similar granules. Basophilia (an elevated absolute basophil count, > 0.10–0.15 ×10⁹/L) is uncommon but clinically significant when present. The most important cause of a persistently high basophil count is chronic myeloid leukaemia (CML): a basophil count > 1% of leukocytes is a diagnostic criterion for CML, and a high percentage (> 20%) at diagnosis predicts a more aggressive course or imminent blast crisis. Other causes of basophilia include polycythaemia vera and other myeloproliferative neoplasms, hypothyroidism, chronic allergic reactions, and some infectious or inflammatory conditions. A low basophil count (basophilopaenia) is rarely of clinical importance. Acute severe allergic reactions and prolonged corticosteroid use can transiently suppress the count. With an otherwise normal blood count, an isolated low basophil count generally has no clinical significance.
Why is Basophils relevant?
Basophils are clinically most relevant in two contexts: as part of the evaluation of myeloproliferative neoplasms (particularly CML) and as a marker in chronic allergic disease. In a preventive blood panel in an otherwise healthy adult they are rarely the marker that demands immediate action — but persistent basophilia that is not explained by an allergic or inflammatory context warrants haematological evaluation, as CML is the primary consideration. For people with chronic allergic conditions — such as allergic asthma, urticaria, or food allergies — the basophil count can sometimes track disease activity. The relationship is not linear enough to use basophils as a routine activity marker, however; total IgE, specific IgE, eosinophils, and tryptase are more sensitive markers for that purpose. Basophils are also involved in protective immunity: they play a role in defence against parasites (together with IgE and eosinophils) and in wound healing through histamine-mediated vasodilation. For most clinical and preventive assessments that physiological role stays in the background — the basophil is a niche marker that becomes clinically active only in specific contexts.
Basophils high or low — what it means
Basophils are almost always interpreted as part of the leukocyte differential, never on their own. The absolute count in ×10⁹/L is more informative than the percentage, because with a low total leukocyte count the percentage can appear disproportionately high. A mildly elevated or low count without symptoms or a matching blood count pattern calls for repeat testing, not immediate action. With a persistently elevated basophil count without a clear cause, the first step is to check whether other myeloproliferative markers are abnormal: polycythaemia (high haemoglobin, high haematocrit), thrombocytosis (high platelet count), or splenomegaly are signs consistent with CML or other myeloproliferative conditions. BCR-ABL1 fusion gene testing (by PCR or FISH) is the diagnostic standard for CML and is appropriate when clinical suspicion exists. For people with known allergic conditions, periodic monitoring of basophils is not a standard approach — total IgE, specific IgE, and eosinophils are the more relevant markers. Basophils provide supporting evidence, not the primary diagnosis. An isolated mildly elevated basophil count in an atopic person during allergy season is almost always non-concerning.
Educational information only — not medical advice. Consult a healthcare professional for clinical decisions.
Read about our scientific approach →